Sale!

F9 Gene Hemophilia B Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The F9 Gene Hemophilia B Genetic Test is a specialized diagnostic procedure designed to identify mutations in the F9 gene, which is responsible for Hemophilia B, also known as Christmas disease. This condition is a genetic disorder that leads to impaired blood clotting, resulting in prolonged bleeding following injury or surgery, and can cause spontaneous bleeding episodes. The test is crucial for the accurate diagnosis of Hemophilia B, enabling healthcare providers to tailor treatment plans and manage the condition effectively.

Conducted at DNA Labs UAE, a leading facility known for its advanced genetic testing services, the test involves analyzing the patient’s DNA sample, usually obtained from a blood draw, to look for specific genetic alterations in the F9 gene that are indicative of Hemophilia B. The process is highly sophisticated, ensuring reliable and accurate results that are essential for the appropriate management of the disorder.

The cost of the F9 Gene Hemophilia B Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the presence of the genetic mutations associated with Hemophilia B. Given the complexity of genetic testing and the specialized technology and expertise required, the cost reflects the value of obtaining a definitive diagnosis, which is crucial for affected individuals and their families to understand the condition and make informed decisions about treatment and management.

Description

F9 Gene Hemophilia B Genetic Test

Test Name: F9 Gene Hemophilia B Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Hematology

Doctor: Hematologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for F9 Gene Hemophilia B NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with F9 Gene Hemophilia B NGS Genetic DNA Test gene F9

Test Details:

The F9 gene hemophilia B NGS genetic test is a type of genetic test that uses next-generation sequencing (NGS) technology to analyze the F9 gene for mutations or variations associated with hemophilia B. Hemophilia B is a genetic bleeding disorder caused by a mutation in the F9 gene, which provides instructions for making a protein called coagulation factor IX.

NGS technology allows for the rapid and efficient sequencing of the entire F9 gene, enabling the identification of specific genetic changes that may be responsible for hemophilia B. This test can provide valuable information for diagnosis, prognosis, and treatment decisions for individuals suspected to have or already diagnosed with hemophilia B.

By identifying the specific genetic mutation or variation, the F9 gene hemophilia B NGS genetic test can help determine the severity of the condition, predict the risk of bleeding episodes, guide treatment options such as factor IX replacement therapy, and provide information for genetic counseling and family planning.

It is important to note that this genetic test should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate recommendations based on the individual’s specific situation.

Test Name	F9 Gene Hemophilia B Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Hematology
Doctor	Hematologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for F9 Gene Hemophilia B NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with F9 Gene Hemophilia B NGS Genetic DNA Test gene F9
Test Details	The F9 gene hemophilia B NGS genetic test is a type of genetic test that uses next-generation sequencing (NGS) technology to analyze the F9 gene for mutations or variations associated with hemophilia B. Hemophilia B is a genetic bleeding disorder caused by a mutation in the F9 gene, which provides instructions for making a protein called coagulation factor IX. NGS technology allows for the rapid and efficient sequencing of the entire F9 gene, enabling the identification of specific genetic changes that may be responsible for hemophilia B. This test can provide valuable information for diagnosis, prognosis, and treatment decisions for individuals suspected to have or already diagnosed with hemophilia B. By identifying the specific genetic mutation or variation, the F9 gene hemophilia B NGS genetic test can help determine the severity of the condition, predict the risk of bleeding episodes, guide treatment options such as factor IX replacement therapy, and provide information for genetic counseling and family planning. It is important to note that this genetic test should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate recommendations based on the individual’s specific situation.